Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 1
1979 2
1980 2
1981 3
1982 3
1983 2
1984 7
1985 4
1986 7
1987 4
1988 2
1989 2
1990 2
1991 2
1992 1
1993 7
1994 3
1995 5
1996 5
1997 6
1998 6
1999 12
2000 5
2001 3
2002 7
2003 11
2004 6
2005 7
2006 11
2007 7
2008 4
2009 6
2010 9
2011 10
2012 22
2013 9
2014 15
2015 15
2016 19
2017 11
2018 14
2019 10
2020 12
2021 19
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

304 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP. Bachert C, et al. Among authors: paggiaro p. Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19. Lancet. 2019. PMID: 31543428 Clinical Trial.
Tiotropium in asthma poorly controlled with standard combination therapy.
Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED. Kerstjens HA, et al. Among authors: paggiaro p. N Engl J Med. 2012 Sep 27;367(13):1198-207. doi: 10.1056/NEJMoa1208606. Epub 2012 Sep 2. N Engl J Med. 2012. PMID: 22938706 Free article. Clinical Trial.
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.
Virchow JC, Kuna P, Paggiaro P, Papi A, Singh D, Corre S, Zuccaro F, Vele A, Kots M, Georges G, Petruzzelli S, Canonica GW. Virchow JC, et al. Among authors: paggiaro p. Lancet. 2019 Nov 9;394(10210):1737-1749. doi: 10.1016/S0140-6736(19)32215-9. Epub 2019 Sep 30. Lancet. 2019. PMID: 31582314 Clinical Trial.
Mepolizumab Effectiveness and Allergic Status in Real Life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: paggiaro p. Int Arch Allergy Immunol. 2021;182(4):311-318. doi: 10.1159/000511147. Epub 2020 Oct 28. Int Arch Allergy Immunol. 2021. PMID: 33113532
Sputum induction.
Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ. Paggiaro PL, et al. Eur Respir J Suppl. 2002 Sep;37:3s-8s. doi: 10.1183/09031936.02.00000302. Eur Respir J Suppl. 2002. PMID: 12361361 Free article. Review. No abstract available.
Cell-derived microparticles and the lung.
Nieri D, Neri T, Petrini S, Vagaggini B, Paggiaro P, Celi A. Nieri D, et al. Among authors: paggiaro p. Eur Respir Rev. 2016 Sep;25(141):266-77. doi: 10.1183/16000617.0009-2016. Eur Respir Rev. 2016. PMID: 27581826 Free article. Review.
Severe asthma: One disease and multiple definitions.
Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, Milanese M, Heffler E, Manfredi A, Riccio AM, De Ferrari L, Blasi F, Canevari RF, Canonica GW, Passalacqua G; SANI (Severe Asthma Network Italy); Severe Asthma Network Italy. Bagnasco D, et al. Among authors: paggiaro p. World Allergy Organ J. 2021 Nov 19;14(11):100606. doi: 10.1016/j.waojou.2021.100606. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34871335 Free PMC article.
Should omalizumab be used in severe asthma/COPD overlap?
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Ricci A, Paggiaro P. Sposato B, et al. Among authors: paggiaro p. J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):755-761. J Biol Regul Homeost Agents. 2018. PMID: 30043557
Factors reducing omalizumab response in severe asthma.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Santus P, Perrella A, Paggiaro PL. Sposato B, et al. Among authors: paggiaro pl. Eur J Intern Med. 2018 Jun;52:78-85. doi: 10.1016/j.ejim.2018.01.026. Epub 2018 Feb 1. Eur J Intern Med. 2018. PMID: 29395935
304 results